UNSPSC 51282130: Flucloxacillin sodium

This classification denotes a penicillin antibiotic with the molecular structure C19H16CLFN3O5S.NA.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, LMG7C674WJ chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, sodium salt monohydrate (2s(2.alpha.,5.alpha.,6.beta.)), but more commonly known as flucloxacillin sodium, which bears US NIH Compound Identifier 21319.

European Medicines Agency schedules Flucloxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02207MIG. Most nations, for tariff and trade purposes, schedule flucloxacillin sodium under HS 29411090. SMILES: CC1C(C(NO1)C2C(CCCC2CL)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].

UNSPSC 51282130 Flucloxacillin sodium is a Commodity code nominally designating a specific antibiotic pharmaceutical product, but state and local solicitations tagged with this code show minimal recent alignment with the pharmaceutical itself. The code does not see active procurement activity for flucloxacillin sodium specifically; instead, recent opportunities classified under it reflect broader pharmaceutical, OTC, and medical-supply procurement that state and local health agencies, fire departments, and multistate cooperative purchasing alliances are conducting. The actual buying activity spans generic pharmaceuticals, naloxone and emergency response medications, medical and first aid supplies for emergency personnel, and direct-to-manufacturer prescription programs — a scope significantly broader than a single antibiotic formulation. Issuing bodies include county health departments (Seminole County, Florida), municipal fire services (City of Tampa), state HHS commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple states including Oregon).

Recent opportunities illustrate the range: Seminole County's IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to support community health initiatives; the City of Tampa's IFB 26P00145 (posted March 25, 2026, response due March 13, 2026) procured 169 line items of medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with a one-year initial term and two one-year renewal options and a sheltered Small Local Business Enterprise (SLBE) set-aside offering a 5 percent bid discount not to exceed $10,000; MMCAP's RFP S1070000015802 (posted January 20, 2026, response due March 26, 2026) established multistate contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers to participating state and local government facilities, with awards effective July 1, 2026, and evaluation weighted 75 percent on price competitiveness; and the Texas HHS Commission issued RFI HHS0017013 (posted April 3, 2026) to solicit vendor capabilities for a direct-to-manufacturer prescription program. The code shows activity across Florida, Texas, Minnesota, and Oregon, though the mismatch between flucloxacillin sodium and the actual procurement scope suggests misclassification in the source data.